{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:54:30Z","timestamp":1790672070210,"version":"4.1.0"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nanotechnology changed our understanding of physics and chemics and influenced the biomedical field. Iron oxide nanoparticles (IONs) are one of the first emerging biomedical applications of nanotechnology. The IONs are composed of iron oxide core exhibiting magnetism and coated with biocompatible molecules. The small size, strong magnetism, and biocompatibility of IONs facilitate the application of IONs in the medical imaging field. We listed several clinical available IONs including Resovist (Bayer Schering Pharma, Berlin, Germany) and Feridex intravenous (I.V.)\/Endorem as magnetic resonance (MR) contrast agents for liver tumor detection. We also illustrated GastroMARK as a gastrointestinal contrast agent for MR imaging. Recently, IONs named Feraheme for treating iron-deficiency anemia have been approved by the Food and Drug Administration. Moreover, tumor ablation by IONs named NanoTherm has also been discussed. In addition to the clinical application, several potential biomedical applications of IONs including cancer-targeting capability by conjugating IONs with cancer-specific ligands, cell trafficking tools, or tumor ablation agents have also been discussed. With the growing awareness of nanotechnology, further application of IONs is still on the horizon that would shed light on biomedicine.<\/jats:p>","DOI":"10.4103\/tcmj.tcmj_65_22","type":"journal-article","created":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T02:03:26Z","timestamp":1658887406000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":37,"title":["Diagnostic and therapeutic roles of iron oxide nanoparticles in biomedicine"],"prefix":"10.4103","volume":"35","author":[{"given":"Chia-Hung","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Medical Imaging, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Kai","family":"Hsiao","sequence":"additional","affiliation":[{"name":"Department of Medical Imaging, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan"},{"name":"School of Medicine, Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,27]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/clinchem\/40.9.1797","article-title":"Nanotechnology: Basic concepts and definitions","volume":"40","author":"Kaehler","year":"1994","journal-title":"Clin Chem"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1021\/acsnano.5b01418","article-title":"Nanoscience versus nanotechnology \u2013 Defining the field","volume":"9","author":"Mulvaney","year":"2015","journal-title":"ACS Nano"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/pharmaceutics6010137","article-title":"Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology","volume":"6","author":"Ait-Oudhia","year":"2014","journal-title":"Pharmaceutics"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.drudis.2016.11.005","article-title":"Doxorubicin: Nanotechnological overviews from bench to bedside","volume":"22","author":"Cagel","year":"2017","journal-title":"Drug Discov Today"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drudis.2019.09.017","article-title":"Clinical applications of nanomedicine in cancer therapy","volume":"25","author":"Norouzi","year":"2020","journal-title":"Drug Discov Today"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1021\/acsbiomaterials.1c00938","article-title":"Iron oxide nanoparticles: Physicochemical characteristics and historical developments to commercialization for potential technological applications","volume":"7","author":"Etemadi","year":"2021","journal-title":"ACS Biomater Sci Eng"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.3390\/ma13204644","article-title":"Magnetic Iron oxide nanoparticle (IONP) synthesis to applications: Present and future","volume":"13","author":"Ajinkya","year":"2020","journal-title":"Materials (Basel)"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11671-008-9174-9","article-title":"Magnetic iron oxide nanoparticles: Synthesis and surface functionalization strategies","volume":"3","author":"Wu","year":"2008","journal-title":"Nanoscale Res Lett"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"12435","DOI":"10.1021\/ie1010965","article-title":"Stable citrate-coated Iron oxide superparamagnetic nanoclusters at high salinity","volume":"49","author":"Kotsmar","year":"2010","journal-title":"Ind Eng Chem Res"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1002\/smll.201303868","article-title":"One-step, room-temperature synthesis of glutathione-capped iron-oxide nanoparticles and their application in in vivo T1-weighted magnetic resonance imaging","volume":"10","author":"Liu","year":"2014","journal-title":"Small"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"16556","DOI":"10.1073\/pnas.262514499","article-title":"Direct imaging of nanoscale magnetic interactions in minerals","volume":"99","author":"Harrison","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"100042","DOI":"10.1016\/j.crgsc.2020.100042","article-title":"A review on synthesis, characterization and potential biological applications of superparamagnetic Iron oxide nanoparticles","volume":"4","author":"Samrot","year":"2021","journal-title":"Curr Opin Green Sustain Chem"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"111601","DOI":"10.1016\/j.jphotobiol.2019.111601","article-title":"Biosynthesis of iron oxide nanoparticles via a composite of psidium guavaja-Moringa oleifera and their antibacterial and photocatalytic study","volume":"199","author":"Madubuonu","year":"2019","journal-title":"J Photochem Photobiol B"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.mattod.2019.06.003","article-title":"Magnetic Iron oxide nanoparticles for disease detection and therapy","volume":"31","author":"Tong","year":"2019","journal-title":"Mater Today (Kidlington)"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/smll.200700493","article-title":"Mesoporous silica nanoparticles improve magnetic labeling efficiency in human stem cells","volume":"4","author":"Liu","year":"2008","journal-title":"Small"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jmri.22504","article-title":"MRI in patients with inflammatory bowel disease","volume":"33","author":"Gee","year":"2011","journal-title":"J Magn Reson Imaging"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pcrysgrow.2008.08.003","article-title":"Synthesis, properties, and applications of magnetic Iron oxide nanoparticles","volume":"55","author":"Teja","year":"2009","journal-title":"Prog CrystGrowth Charact Mater"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1109\/TMAG.2007.893860","article-title":"Comparison of micrometer and nanometer sized magnetic particles for cell labeling","volume":"43","author":"Hsiao","year":"2007","journal-title":"IEEE Trans Magn"},{"key":"R19-20240828","first-page":"07B314","article-title":"Labeling of human mesenchymal stem cell: Comparison between paramagnetic and superparamagnetic agents","volume":"105","author":"Yang","year":"2009","journal-title":"AJP"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"14153","DOI":"10.1039\/C8NR03084G","article-title":"PEG-copolymer-coated iron oxide nanoparticles that avoid the reticuloendothelial system and act as kidney MRI contrast agents","volume":"10","author":"G\u00f3mez-Vallejo","year":"2018","journal-title":"Nanoscale"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/s41598-018-19628-z","article-title":"Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings","volume":"8","author":"Feng","year":"2018","journal-title":"Sci Rep"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0169-409X(02)00026-1","article-title":"PEGylated antibodies and antibody fragments for improved therapy: A review","volume":"54","author":"Chapman","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.05.015","article-title":"Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer","volume":"99","author":"Yeh","year":"2016","journal-title":"Biomaterials"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/RLI.0b013e3181ee6a49","article-title":"High-relaxivity magnetic resonance imaging contrast agents. Part 2. Optimization of inner- and second-sphere relaxivity","volume":"45","author":"Jacques","year":"2010","journal-title":"Invest Radiol"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"e25524","DOI":"10.1371\/journal.pone.0025524","article-title":"Mechanism of cellular uptake and impact of ferucarbotran on macrophage physiology","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.5012\/bkcs.2006.27.7.1038","article-title":"Synthesis and magnetic relaxation properties of paramagnetic Gd-complexes of new DTPA-bis-amides. The X-ray crystal structure of Gd (L)(H2O) 3H2O (L=DTPA-bis (4-carboxylicphenyl) amide)","volume":"27","author":"Dutta","year":"2006","journal-title":"Bull Korean Chem Soc"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/s00330-002-1721-7","article-title":"Ferucarbotran (Resovist): A new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: Properties, clinical development, and applications","volume":"13","author":"Reimer","year":"2003","journal-title":"Eur Radiol"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3348\/kjr.2002.3.2.87","article-title":"Optimal pulse sequence for ferumoxides-enhanced MR imaging used in the detection of hepatocellular carcinoma: A comparative study using seven pulse sequences","volume":"3","author":"Kim","year":"2002","journal-title":"Korean J Radiol"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3174\/ajnr.A5896","article-title":"A review of magnetic particle imaging and perspectives on neuroimaging","volume":"40","author":"Wu","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.3402\/nano.v1i0.5358","article-title":"Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)","volume":"1","author":"Singh","year":"2010","journal-title":"Nano Rev"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/17435390.2019.1698779","article-title":"Mechanisms for cellular uptake of nanosized clinical MRI contrast agents","volume":"14","author":"Guggenheim","year":"2020","journal-title":"Nanotoxicology"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.rli.0000101027.57021.28","article-title":"Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: Mechanisms and comparison of ferumoxides and ferumoxtran-10","volume":"39","author":"Raynal","year":"2004","journal-title":"Invest Radiol"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/mrm.21377","article-title":"Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent: Cellular behavior and capability of detection with clinical 1.5 T magnetic resonance at the single cell level","volume":"58","author":"Hsiao","year":"2007","journal-title":"Magn Reson Med"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/nbm.1260","article-title":"Macrophage physiological function after superparamagnetic iron oxide labeling","volume":"21","author":"Hsiao","year":"2008","journal-title":"NMR Biomed"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1089\/ten.tec.2014.0110","article-title":"Viability, differentiation capacity, and detectability of super-paramagnetic iron oxide-labeled muscle precursor cells for magnetic-resonance imaging","volume":"21","author":"Azzabi","year":"2015","journal-title":"Tissue Eng Part C Methods"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"e31137","DOI":"10.1371\/journal.pone.0031137","article-title":"MRI of auto-transplantation of bone marrow-derived stem-progenitor cells for potential repair of injured arteries","volume":"7","author":"Meng","year":"2012","journal-title":"PLoS One"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/nbm.1487","article-title":"The effects of clinically used MRI contrast agents on the biological properties of human mesenchymal stem cells","volume":"23","author":"Kim","year":"2010","journal-title":"NMR Biomed"},{"key":"R38-20240828","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1016\/j.biomaterials.2009.03.032","article-title":"The promotion of human mesenchymal stem cell proliferation by superparamagnetic Iron oxide nanoparticles","volume":"30","author":"Huang","year":"2009","journal-title":"Biomaterials"},{"key":"R39-20240828","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11051-009-9589-y","article-title":"Immunological impact of magnetic nanoparticles (Ferucarbotran) on murine peritoneal macrophages","volume":"12","author":"Yeh","year":"2010","journal-title":"J Nanoparticle Res"},{"key":"R40-20240828","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1038\/s41598-017-03863-x","article-title":"Characterization of an iron oxide nanoparticle labelling and MRI-based protocol for inducing human mesenchymal stem cells into neural-like cells","volume":"7","author":"Lu","year":"2017","journal-title":"Sci Rep"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1039\/C7NR06976F","article-title":"Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson's disease","volume":"10","author":"Chung","year":"2018","journal-title":"Nanoscale"},{"key":"R42-20240828","first-page":"35","article-title":"Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application","volume":"1","author":"Wang","year":"2011","journal-title":"Quant Imaging Med Surg"},{"key":"R43-20240828","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1208\/s12248-015-9780-2","article-title":"A review of clinical translation of inorganic nanoparticles","volume":"17","author":"Anselmo","year":"2015","journal-title":"AAPS J"},{"key":"R44-20240828","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/nbm.991","article-title":"Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells","volume":"18","author":"Arbab","year":"2005","journal-title":"NMR Biomed"},{"key":"R45-20240828","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s11547-009-0464-9","article-title":"MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: Pathological correlation in explanted livers","volume":"114","author":"Macarini","year":"2009","journal-title":"Radiol Med"},{"key":"R46-20240828","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1148\/radiol.2203001777","article-title":"Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: Importance of Kupffer cell number","volume":"220","author":"Lim","year":"2001","journal-title":"Radiology"},{"key":"R47-20240828","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.510240409","article-title":"Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver","volume":"24","author":"Tanaka","year":"1996","journal-title":"Hepatology"},{"key":"R48-20240828","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.3748\/wjg.v21.i14.4334","article-title":"Superparamagnetic iron oxide-enhanced magnetic resonance imaging for focal hepatic lesions: Systematic review and meta-analysis","volume":"21","author":"Li","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R49-20240828","first-page":"181","article-title":"Diagnostic accuracy of MR imaging to identify and characterize focal liver lesions: Comparison between gadolinium and superparamagnetic iron oxide contrast media","volume":"4","author":"Maurea","year":"2014","journal-title":"Quant Imaging Med Surg"},{"key":"R50-20240828","first-page":"219","article-title":"Benign hepatic tumors: MRI features before and after administration of superparamagnetic contrast media","volume":"101","author":"Bartolotta","year":"2001","journal-title":"Radiol Med"},{"key":"R51-20240828","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/jmri.21937","article-title":"Resovist enhanced MR imaging of the liver: Does quantitative assessment help in focal lesion classification and characterization?","volume":"30","author":"Santoro","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"R52-20240828","first-page":"e9269","article-title":"Atypical findings of focal nodular hyperplasia with gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging","volume":"11","author":"Yoon","year":"2014","journal-title":"Iran J Radiol"},{"key":"R53-20240828","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/00004424-199611000-00004","article-title":"Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient","volume":"31","author":"Vogl","year":"1996","journal-title":"Invest Radiol"},{"key":"R54-20240828","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0046-8177(91)90039-R","article-title":"Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma","volume":"22","author":"Sakamoto","year":"1991","journal-title":"Hum Pathol"},{"key":"R55-20240828","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1053\/jhep.2000.9113","article-title":"Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: Correlation with histological grading","volume":"32","author":"Imai","year":"2000","journal-title":"Hepatology"},{"key":"R56-20240828","first-page":"2058460117727315","article-title":"Efficacy of oral contrast agents for upper gastrointestinal signal suppression in MRCP: A systematic review of the literature","volume":"6","author":"Frisch","year":"2017","journal-title":"Acta Radiol Open"},{"key":"R57-20240828","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00247-007-0644-5","article-title":"MR cholangiopancreatography in children: Feasibility, safety, and initial experience","volume":"38","author":"Delaney","year":"2008","journal-title":"Pediatr Radiol"},{"key":"R58-20240828","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1073\/pnas.1620145114","article-title":"Exceedingly small iron oxide nanoparticles as positive MRI contrast agents","volume":"114","author":"Wei","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R59-20240828","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1021\/acs.molpharmaceut.9b00632","article-title":"Feraheme (Ferumoxytol) is recognized by proinflammatory and anti-inflammatory macrophages via scavenger receptor type AI\/II","volume":"16","author":"Wang","year":"2019","journal-title":"Mol Pharm"},{"key":"R60-20240828","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2215\/CJN.05320513","article-title":"A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD","volume":"9","author":"Macdougall","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R61-20240828","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41565-019-0406-1","article-title":"FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels","volume":"14","author":"Trujillo-Alonso","year":"2019","journal-title":"Nat Nanotechnol"},{"key":"R62-20240828","doi-asserted-by":"crossref","first-page":"17501","DOI":"10.3390\/ijms140917501","article-title":"Materials characterization of Feraheme\/ferumoxytol and preliminary evaluation of its potential for magnetic fluid hyperthermia","volume":"14","author":"Bullivant","year":"2013","journal-title":"Int J Mol Sci"},{"key":"R63-20240828","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.nano.2015.03.011","article-title":"A multifunctional peptide for targeted imaging and chemotherapy for nasopharyngeal and breast cancers","volume":"11","author":"Hsiao","year":"2015","journal-title":"Nanomedicine"},{"key":"R64-20240828","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.7150\/thno.17573","article-title":"Lung cancer-targeting peptides with multi-subtype indication for combinational drug delivery and molecular imaging","volume":"7","author":"Chi","year":"2017","journal-title":"Theranostics"},{"key":"R65-20240828","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00775-008-0445-9","article-title":"Targeted herceptin-dextran iron oxide nanoparticles for noninvasive imaging of HER2\/neu receptors using MRI","volume":"14","author":"Chen","year":"2009","journal-title":"J Biol Inorg Chem"},{"key":"R66-20240828","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.1016\/j.biomaterials.2012.06.100","article-title":"Multimodality treatment of cancer with herceptin conjugated, thermomagnetic iron oxides and docetaxel loaded nanoparticles of biodegradable polymers","volume":"33","author":"Mi","year":"2012","journal-title":"Biomaterials"},{"key":"R67-20240828","doi-asserted-by":"crossref","first-page":"101896","DOI":"10.1016\/j.pdpdt.2020.101896","article-title":"Trastuzumab conjugated porphyrin-superparamagnetic iron oxide nanoparticle: A potential PTT-MRI bimodal agent for herceptin positive breast cancer","volume":"31","author":"Khaniabadi","year":"2020","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"R68-20240828","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11060-010-0389-0","article-title":"Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme","volume":"103","author":"Maier-Hauff","year":"2011","journal-title":"J Neurooncol"},{"key":"R69-20240828","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.2147\/IJN.S278687","article-title":"Bidirectional enhancement of cell proliferation between iron oxide nanoparticle-labeled mesenchymal stem cells and choroid plexus in a cell-based therapy model of ischemic stroke","volume":"15","author":"Wu","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"R70-20240828","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1016\/j.biomaterials.2011.01.042","article-title":"In vivo magnetic resonance imaging of cell tropism, trafficking mechanism, and therapeutic impact of human mesenchymal stem cells in a murine glioma model","volume":"32","author":"Chien","year":"2011","journal-title":"Biomaterials"},{"key":"R71-20240828","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11307-016-1001-6","article-title":"Targeted superparamagnetic Iron OXIDE NANOPARTICLES for in vivo magnetic resonance imaging of T-cells in rheumatoid arthritis","volume":"19","author":"Chen","year":"2017","journal-title":"Mol Imaging Biol"},{"key":"R72-20240828","doi-asserted-by":"crossref","first-page":"506","DOI":"10.7150\/thno.49812","article-title":"Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles","volume":"11","author":"Tong","year":"2021","journal-title":"Theranostics"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_65_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:05:43Z","timestamp":1787756743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_65_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,27]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_65_22","relation":{},"ISSN":["1016-3190","2223-8956"],"issn-type":[{"value":"1016-3190","type":"print"},{"value":"2223-8956","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,27]]},"assertion":[{"value":"2022-03-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}